We prospectively evaluated interferon (IFN)-α (type I IFN) levels in a cohort of hospitalized COVID-19 patients with respiratory failure and we followed the evolution of the clinical manifestations of the clinical conditions in parallel with immune/inflammatory profile variations. This evidence concerns the gene IFNA1 and respiratory failure.